<scp>MUC</scp>1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanismDina Stroopinsky(Beth Israel Deaconess Medical Center), David Avigan(Beth Israel Deaconess Medical Center)Journal of Cellular and Molecular MedicineMay 15, 201810.1111/jcmm.13662Cited by 15SaveCiteExport RISWatch citationsRelated PapersVaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma|Blood|2010|226